This document is an excerpt from the EUR-Lex website
Document 62017TJ0354
Judgment of the General Court (Sixth Chamber) of 23 April 2018.#Genomic Health, Inc. v European Union Intellectual Property Office.#EU trade mark — Application for EU word mark ONCOTYPE DX GENOMIC PROSTATE SCORE — Absolute ground for refusal — Descriptiveness — Article 7(1)(c) of Regulation (EC) No 207/2009 (now Article 7(1)(c) of Regulation (EU) 2017/1001) — Equal treatment.#Case T-354/17.
Judgment of the General Court (Sixth Chamber) of 23 April 2018.
Genomic Health, Inc. v European Union Intellectual Property Office.
EU trade mark — Application for EU word mark ONCOTYPE DX GENOMIC PROSTATE SCORE — Absolute ground for refusal — Descriptiveness — Article 7(1)(c) of Regulation (EC) No 207/2009 (now Article 7(1)(c) of Regulation (EU) 2017/1001) — Equal treatment.
Case T-354/17.
Judgment of the General Court (Sixth Chamber) of 23 April 2018.
Genomic Health, Inc. v European Union Intellectual Property Office.
EU trade mark — Application for EU word mark ONCOTYPE DX GENOMIC PROSTATE SCORE — Absolute ground for refusal — Descriptiveness — Article 7(1)(c) of Regulation (EC) No 207/2009 (now Article 7(1)(c) of Regulation (EU) 2017/1001) — Equal treatment.
Case T-354/17.
ECLI identifier: ECLI:EU:T:2018:212